בוקולאם 5 מ"ג

Pays: Israël

Langue: hébreu

Source: Ministry of Health

Ingrédients actifs:

MIDAZOLAM AS HYDROCHLORIDE 5 MG

Disponible depuis:

NEOPHARM CURE (2005) LTD

Code ATC:

N05CD08

forme pharmaceutique:

OROMUCOSAL SOLUTION

Mode d'administration:

BUCCAL

Fabriqué par:

SCM PHARMA LIMITED, UK

Groupe thérapeutique:

MIDAZOLAM

indications thérapeutiques:

Treatment of prolonged, acute, convulsive seizures in infants, toddlers, children and adolescents (from 3 months to < 18 years). Buccolam must only be used by parents/carers where the patient has been diagnosed to have epilepsy. For infants between 3-6 months of age treatment should be in a hospital setting where monitoring is possible and resuscitation equipment is available.

Date de l'autorisation:

2013-05-01